Patents by Inventor Kaija Halonen

Kaija Halonen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the alleviation of dyspareunia in women
    Patent number: 9566252
    Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: February 14, 2017
    Assignee: HORMOS MEDICAL LTD.
    Inventors: Kaija Halonen, Lauri Kangas, Michael W. DeGregorio
  • SOLID FORMULATIONS OF OSPEMIFENE
    Publication number: 20140220118
    Abstract: This invention relates to a solid drug formulation comprising granulates containing• a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.
    Type: Application
    Filed: January 30, 2014
    Publication date: August 7, 2014
    Inventors: Veli-Matti LEHTOLA, Kaija HALONEN
  • METHODS FOR THE ALLEVIATION OF SEXUAL DYSFUNCTION IN WOMEN
    Publication number: 20140142195
    Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 22, 2014
    Applicants: HORMOS MEDICAL LTD.
    Inventors: Kaija HALONEN, Lauri KANGAS, Michael W. DEGREGORIO
  • Solid formulations of ospemifene
    Patent number: 8642079
    Abstract: This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: February 4, 2014
    Assignee: Hormos Medical Corporation
    Inventors: Veli-Matti Lehtola, Kaija Halonen
  • METHODS FOR THE INHIBITION OF ATROPHY OR FOR TREATMENT OR PREVENTION OF ATROPHY-RELATED SYMPTOMS IN WOMEN
    Publication number: 20100280131
    Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof
    Type: Application
    Filed: July 15, 2010
    Publication date: November 4, 2010
    Inventors: Taru Blom, Paula Grönroos, Kaija Halonen, Pirkko Härkönen
  • Novel oral formulations of ospemifene
    Publication number: 20070104742
    Abstract: This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: November 6, 2006
    Publication date: May 10, 2007
    Applicant: HORMOS MEDICAL LTD.
    Inventors: Veli-Matti Lehtola, Kaija Halonen
  • Formulations of fispemifene
    Publication number: 20070104743
    Abstract: This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a mixture of isomers, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: November 9, 2006
    Publication date: May 10, 2007
    Applicant: HORMOS MEDICAL LTD.
    Inventors: Veli-Matti Lehtola, Kaija Halonen
  • Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
    Patent number: 6984665
    Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: January 10, 2006
    Assignee: Hormos Medical Corporation
    Inventors: Taru Blom, Paula Grönroos, Kaija Halonen, Pirkko Härkönen
  • Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
    Publication number: 20050272825
    Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.
    Type: Application
    Filed: August 11, 2005
    Publication date: December 8, 2005
    Applicant: Hormos Medical Corporation
    Inventors: Taru Blom, Paula Gronroos, Kaija Halonen, Pirkko Harkonen
  • Solid formulations of ospemifene
    Publication number: 20050187301
    Abstract: This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.
    Type: Application
    Filed: February 23, 2004
    Publication date: August 25, 2005
    Applicant: Hormos Medical Corporation
    Inventors: Veli-Matti Lehtola, Kaija Halonen
  • Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
    Publication number: 20030036566
    Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) 1
    Type: Application
    Filed: June 6, 2002
    Publication date: February 20, 2003
    Applicant: Hormos Medical Corporation
    Inventors: Taru Blom, Paula Gronroos, Kaija Halonen, Pirkko Harkonen
  • Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents
    Patent number: 6316431
    Abstract: This invention relates to the use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ration (DATER) as well as to a method for the treatment of detrusor urethral sphincter dyssnergia (DUSD) in men.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: November 13, 2001
    Assignee: Hormors Medical Oy Ltd.
    Inventors: Risto Santti, Antti Talo, Tomi Streng, Kaija Halonen, Lauri Kangas, Risto Lammintausta
  • Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
    Patent number: 6245819
    Abstract: This invention concerns a method for the treatment of vaginal dryness or sexual dysfunction in women during or after the menopause, said method comprising administering to the woman an effective amount of the compound (deaminohydroxy)toremifene or a pharmaceutically acceptable salt or ester thereof, or a metabolite thereof.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: June 12, 2001
    Assignees: Hormos Medical Oy, Ltd., Tess Diagnostics and Pharmaceuticals, Inc.
    Inventors: Kaija Halonen, Lauri Kangas, Michael W. DeGregorio
  • Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
    Patent number: 5972921
    Abstract: The invention relates to a method for the treatment of detrusor urethral sphincter dyssynergia in men, said method comprising administering to the patient an effective amount of an aromatase inhibitor. The invention also concerns a method for the treatment of decreased androgen to estrogen ratio in men, said method comprising administering to the patient an effective amount of an aromatase inhibitor.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: October 26, 1999
    Assignee: Hormos Medical Oy Ltd.
    Inventors: Risto Santti, Antti Talo, Tomi Streng, Kaija Halonen, Lauri Kangas, Risto Lammintausta